Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. (Q53560469)

15 May 2018

title

Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. (English)

1 reference

15 May 2018

1 reference

1 reference

Lubeck DP

1

1 reference

15 May 2018

Litwin MS

2

1 reference

15 May 2018

Henning JM

3

1 reference

15 May 2018

Stoddard ML

4

1 reference

15 May 2018

Flanders SC

5

1 reference

15 May 2018

Carroll PR

6

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

15 May 2018

published in

Urology

1 reference

15 May 2018

volume

53

1 reference

15 May 2018

page(s)

180-186

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Patient-Reported Impotence and Incontinence After Nerve-Sparing Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Strategies for the management of recurrent and advanced urologic cancers. Quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Sex or survival: trade-offs between quality and quantity of life

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Patient-re ported complications and follow-up treatment after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900408-7

7 January 2021

10.1016/S0090-4295(98)00408-7

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

9886609

1 reference

15 May 2018